Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2010

01-10-2010 | Poster presentation

Mammographic follow-up of patients after treatment for breast cancer: is 5 years enough?

Authors: D Vaile, LB Williams, AC Borley, PJ Barrett-Lee, P Young

Published in: Breast Cancer Research | Special Issue 3/2010

Login to get access

Excerpt

Velindre Cancer Centre (VCC), Cardiff provides radiotherapy and oncology services to the population of 1.5 million across southeast Wales. Historically at Velindre, breast cancer patients are followed up for at least 10 years, with annual mammography underpinning the service. The optimal length for continued annual surveillance has been debated and reduction to 5 years follow-up suggested. Therefore, a retrospective audit of breast cancers diagnosed on follow-up mammograms was undertaken to support the proposed reduced length of mammographic follow-up. …
Metadata
Title
Mammographic follow-up of patients after treatment for breast cancer: is 5 years enough?
Authors
D Vaile
LB Williams
AC Borley
PJ Barrett-Lee
P Young
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 3/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2661

Other articles of this Special Issue 3/2010

Breast Cancer Research 3/2010 Go to the issue

Poster presentation

How can the prevalent round recall rate be reduced?

Poster presentation

Is digital better?

Poster presentation

Educational abstract

Poster presentation

Fine needle aspiration versus touch imprint cytology in ultrasound-guided core of breast masses

Poster presentation

What is involved in a comprehensive breast MRI service? Implications for service provision

Poster presentation

Breast cancer in 35 to 39 year olds and imaging: is changing to ultrasound without mammography going to be safe? What are the workload implications?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits